Joel Neoh, Managing Director at CircleDNA and Chief Consumer Officer at Prenetics
Joel Neoh, Co-Founder and former CEO of fintech platform Fave, has been appointed as the Managing Director of CircleDNA, a wholly-owned subsidiary of Prenetics Global, a genomics and oncology company listed on the Nasdaq.
Neoh will also be taking on the role of Prenetics’s Chief Consumer Officer.
The appointment comes when CircleDNA is undergoing a transformative phase expanding into new verticals and introducing a wide range of personalised healthcare offerings to its customers.
CircleDNA is extending its scope to encompass preventive and personalised healthcare management, with plans to forge local-country partnerships and integrate a comprehensive range of services, including blood tests, telehealth services, tailored supplements, and online-to-offline healthcare services. Over the next 12 months, the firm will introduce these new products and services.
Also Read: TradeMonday gets SenseTime backing to expand its retail analytics solutions
“As an entrepreneur who has received significant support, particularly in Southeast Asia, I strongly desire to contribute back to the community by promoting health and emphasising the importance of preventive care,” shared Neoh.
Founded in 2014 to transform patient care through advanced genomic and molecular technologies, Prenetics has operations in Hong Kong and the UK, processing over 28 million PCR and at-home test kits. Prenetics was listed on the NASDAQ in 2022.
CircleDNA, the consumer health business of Prenetics, facilitates individuals in actively managing their health through valuable health insights derived from their DNA.
Since 2020, CircleDNA claims to have served over 300,000 customers worldwide with its DNA tests using whole exome sequencing technology. Its mobile app grants customers access to a wide array of genetic information, with over 500 reports across 20 categories, covering disease risks, drug responses, family planning, diet, common health risks, personal traits, and nutrition, among others.
As of March 31, 2023, Prenetics holds US$224.1 million in cash and other short-term assets.
—
Echelon Asia Summit 2023 brings together APAC’s leading startups, corporates, policymakers, industry leaders, and investors to Singapore this June 14-15. Learn more and get tickets here. Echelon also features the TOP100 stage, where startups can pitch to 5000+ delegates, among other benefits like connecting with investors, visibility through the platform, and other prizes. Join TOP100 here.
The post Fave Co-Founder Joel Neoh to head Prenetics’s consumer health subsidiary CircleDNA appeared first on e27.